Purpose: To determine through meta-analysis whether administration of statins before carotid artery stenting (CAS) is associated with fewer periprocedural adverse events. Methods: All randomized and observational English-language studies of periprocedural statin administration prior to CAS that reported the outcomes of interest (stroke, transient ischemic attack, myocardial infarction, and death at 30 days) were included in a random-effects meta-analysis. The I2 statistic was used to assess heterogeneity. Meta-regression analysis was performed to determine whether an association of statin treatment with risk of outcome events was influenced by other trial-level baseline characteristics of statin-treated and untreated patients. Results: Eleven studies comprising 4088 patients were included. Patients who received statins prior to CAS had a significantly lower risk of stroke (OR 0.39, 95% CI 0.27 to 0.58, p<0.01; I2=0%) and death (OR 0.30, 95% CI 0.10 to 0.96, p=0.042; I2=0%). Statin use was not associated with a reduced risk of transient ischemic attack or myocardial infarction. In meta-regression analysis, other trial-level baseline characteristics had no significant influence on the association of statin treatment with death or stroke. Conclusion: Statin therapy prior to CAS is associated with decreased risk of perioperative stroke and death without any effect on the rates of transient ischemic attack or myocardial infarction.
AlricPBranchereauPBerthetJ-Pet al. Carotid artery stenting for stenosis following revascularization or cervical irradiation. J Endovasc Ther. 2002;9:14–19.
2.
EconomopoulosKPSergentanisTNTsivgoulisGet al. Carotid artery stenting versus carotid endarterectomy: A comprehensive meta-analysis of short-term and long-term outcomes. Stroke. 2011;42:687–692.
3.
MusialekPHopf-JensenS.Commentary: Carotid artery revascularization for stroke prevention : a new era. J Endovasc Ther. 2017;24:138–148.
4.
MusialekPMazurekATrystulaMet al. Novel PARADIGM in carotid revascularisation: Prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuard MicroNet-covered embolic prevention stent system. EuroIntervention. 2016;12:e658–e670.
5.
MudraHStaubachSHein-RothweilerRet al. Long-term outcomes of carotid artery stenting in clinical practice. Circ Cardiovasc Interv. 2016;9:e003940. doi:10.1161/CIRCINTERVENTIONS.116.003940.
6.
LiYYangJ-JZhuS-Het al. Long-term efficacy and safety of carotid artery stenting versus endarterectomy: A meta-analysis of randomized controlled trials. PLoS One. 2017;12:e0180804.
7.
SardarPChatterjeeSAronowHDet al. Carotid artery stenting versus endarterectomy for stroke prevention a meta-analysis of clinical trials. J Am Coll Cardiol. 2017;69:2266–2275.
8.
TadrosROVouyoukaAGChungCet al. The effect of statin use on embolic potential during carotid angioplasty and stenting. Ann Vasc Surg. 2013;27:96–103.
9.
Castilla-GuerraLDel Carmen Fernandez-MorenoMColmenero-CamachoMA.Statins in stroke prevention: present and future. Curr Pharm Des. 2016;22:4638–4644.
10.
NakamuraMFukukawaTKitagawaKet al. Ten-year standardization of lipids and high-sensitivity C-reactive protein in a randomized controlled trial to assess the effects of statins on secondary stroke prevention: Japan Statin Treatment Against Recurrent Stroke. Ann Clin Biochem. 2018;55:128–135. doi:10.1177/0004563217693651.
11.
LevineGNBatesERBlankenshipJCet al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography. Circulation. 2011;124:2574–2609.
12.
ChanAWBhattDLChewDPet al. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation. 2002;105:691–696.
13.
TentzerisIRohlaMJaraiRet al. Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes. Am J Cardiol. 2014;113:1099–1104.
14.
PattiGTomaiFMelfiRet al. Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting. J Am Coll Cardiol. 2013;61:1379–1387.
15.
DavignonJ.Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109(23suppl 1):III-39–III-43.
16.
TakayamaKTakiWTomaNet al. Effect of pitavastatin on preventing ischemic complications with carotid artery stenting: a multicenter prospective study—EPOCH-CAS study. Cardiovasc Intervent Radiol. 2013;37:1436–1443.
17.
ShamseerLMoherDClarkeMet al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.
18.
HigginsJPAltmanDGGøtzschePCet al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d5928.
19.
SterneJAHernanMAReevesBCet al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
20.
HigginsJPTThompsonSGDeeksJJet al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
21.
GaudetJGMeyersPMMcKinseyJFet al. Incidence of moderate to severe cognitive dysfunction in patients treated with carotid artery stenting. Neurosurgery. 2009;65:325–329.
22.
GroschelKErnemannUSchulzJBet al. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology. 2006;240:145–151.
23.
HongJ-HSohnS-IKwakJet al. Dose-dependent effect of statin pretreatment on preventing the periprocedural complications of carotid artery stenting. Stroke. 2017;48:1890–1894.
24.
InoueRSakataNNakaiKet al. Nε-(carboxymethyl)lysine in debris from carotid artery stenting: multiple versus nonmultiple postoperative lesions. J Stroke Cerebrovasc Dis. 2014;23:2827–2833.
SorgunMHIşikayCTAratA.Effects of statin treatment on early outcomes and restenosis after carotid stenting [Statin tedavisinin karotis stentleme sonrası erken sonuçlar ve restenoza etkisi]. J Neurol Sci. 2014;31:435–441.
27.
VerziniFDe RangoPParlaniGet al. Effects of statins on early and late results of carotid stenting. J Vasc Surg. 2011;53:71–79.
28.
ZhengJ-XJiaoL-QLingFet al. Effects of statins on the prognosis of carotid artery stenting. Chinese J Cerebrovasc Dis. 2014;11:123–126.
29.
KennedyJQuanHBuchanAMet al. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke. 2005;36:2072–2076.
30.
McGirtMJPerlerBABrookeBSet al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg. 2005;42:827–829.
31.
AbuRahmaAFSrivastavaMStonePAet al. Effect of statins on early and late clinical outcomes of carotid endarterectomy and the rate of post-carotid endarterectomy restenosis. J Am Coll Surg. 2015;220:481–487.
32.
PasceriVPattiGNuscaAet al. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 2004;110:674–678.
33.
De RangoPParlaniGVerziniFet al. Long-term prevention of stroke: A modern comparison of current carotid stenting and carotid endarterectomy. J Am Coll Cardiol. 2011;57:664–671.
34.
WallaertJBCronenwettJLBertgesDJet al. Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival. J Vasc Surg. 2013;58:112–119.
35.
Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670–1681.
36.
CalabroPYehETH. The pleiotropic effects of statins. Curr Opin Cardiol. 2005;20:541–546.
37.
TakemotoMLiaoJK.Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol. 2001;21:1712–1719.
38.
RayKKCannonCP.The Potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol. 2005;46:1425–1433.
39.
AntoniouGAHajibandehSHajibandehSet al. Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery. J Vasc Surg. 2015;61:519–532.
40.
Della-MorteDMoussaIElkindMSet al. The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study. Neurol Res. 2011;33:991–994.
41.
AbelaGSVedreAJanoudiAet al. Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. Am J Cardiol. 2011;107:1710–1717.
42.
SterneJACSuttonAJIoannidisJPAet al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
